Takeda agrees to $2.4 billion settlement in Actos bladder cancer litigation

by Eric Pearson

Takeda Pharmaceuticals has agreed to pay $2.4 billion to settle thousands of lawsuits filed by patients who developed bladder cancer after taking the diabetes drug Actos. The Actos settlement agreement will one of the largest pharmaceutical liability settlements ever reached.

Concerns about the link between Actos and bladder cancer arose following reports that patients who took the drug for more than one year were more likely to be diagnosed with bladder cancer. This information prompted officials in France and Germany to recall Actos. In the U.S., Food and Drug Administration officials added a black box warning to the Actos label alerting patients that the drug could increase their risk of bladder cancer.

Lawsuits filed against Takeda allege that the company had concealed or downplayed the link between Actos and bladder cancer from patients before the drug went on sale in 1999. The lawsuits also accuse Takeda of hiding information about the side effects of Actos from regulators before the drug was approved in the U.S.

The Actos settlement agreement comes about one year after a Louisiana man who developed bladder cancer after taking the diabetes drug obtained a judgment for $27.7 million against Takeda and $9.2 million against Eli Lilly.

Some business experts say that plaintiffs who have been seriously injured as a result of using Actos may choose to opt out of the settlement because they may be eligible to receive higher compensation for their injuries. Takeda has reportedly set aside $300 million to cover addition costs related to Actos lawsuits against the company.

According to one attorney representing Actos patients, the $2.4 billion settlement will be divided between about 9,000 individuals who filed lawsuits against Takeda. Actos users included in the settlement would receive about $267,000 each. The settlement agreement would become effective if 95% of Actos plaintiffs choose to accept the settlement offer.

Actos Users May Still Qualify to File a Lawsuit

Actos users who have been diagnosed with bladder cancer may still qualify to file a lawsuit and receive compensation for their injuries. The first step in filing an Actos bladder cancer lawsuit is to speak with an experienced pharmaceutical litigation attorney who has the knowledge and experience to successfully handle your case from start to finish.

The lawyers at Heygood, Orr & Pearson are pursuing Actos cases on behalf of clients who were diagnosed with bladder cancer after being prescribed the diabetes drug. Our law firm will be closely involved with the Actos multidistrict litigation (MDL) and other lawsuits filed against Actos involving bladder cancer.

Our attorneys have extensive experience in handling lawsuits involving dangerous drugs or defective medical devices, including cases involving the fentanyl pain patch, Yaz, Avandia, and other drugs. Our lawyers have successfully achieved verdicts and settlements of more than $200 million for our clients in lawsuits relating to defective drugs products or other medical products.

For a free legal consultation about your case to find out more about whether you may be eligible to file a lawsuit involving Actos and bladder cancer, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001, or by following this link to our free case evaluation form.

by Eric Pearson

Eric Pearson is a licensed attorney and a partner at HO&P who handles commercial and personal injury lawsuits. Eric has been selected to the Super Lawyers List, a Thomson Reuters publication.